Awareness Enhancing Interventions

NCT04683510 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4451

Last updated 2025-05-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if increasing awareness and, thus, enhancing positive attitudes about research, prior to recruitment attempts, will increase participation in cancer clinical research among African American (AA) cancer survivors so that recruitment efforts can focus on the most optimal and cost- effective approaches

Conditions

  • Research Awareness

Interventions

OTHER

Navigation - Study Specific - Researcher Voice

The intervention is delivered over the telephone

OTHER

Navigation - Study Specific - Cancer Survivor Voice

The intervention is delivered over the telephone

OTHER

Navigation - Research General - Researcher Voice

The intervention is delivered over the telephone

OTHER

Navigation - Research General - Cancer Survivor Voice

The intervention is delivered over the telephone

OTHER

Brochure - Study Specific - Researcher Voice

The invention is mailed to the participant in a brochure.

OTHER

Brochure - Study Specific - Cancer Survivor Voice

The invention is mailed to the participant in a brochure.

OTHER

Brochure - Research General - Researcher Voice

The invention is mailed to the participant in a brochure.

OTHER

Brochure - Research General - Cancer Survivor Voice

The invention is mailed to the participant in a brochure.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • University of Alabama at Birmingham

    collaborator OTHER
  • University of Tennessee

    lead OTHER

Principal Investigators

  • Michelle Y Marttin, PhD · University of Tennessee

  • Maria Pisu, PhD · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-12
Primary Completion
2024-03-31
Completion
2025-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04683510 on ClinicalTrials.gov